Cargando…
Impact of overlapping risks of type 2 diabetes and obesity on coronavirus disease severity in the United States
The impact of overlapping risk factors on coronavirus disease (COVID-19) severity is unclear. To evaluate the impact of type 2 diabetes (T2D) and obesity on COVID-19 severity, we conducted a cohort study with 28,095 anonymized COVID-19 patients using data from the COVID-19 Research Database from Jan...
Autores principales: | Ando, Wataru, Horii, Takeshi, Uematsu, Takayuki, Hanaki, Hideaki, Atsuda, Koichiro, Otori, Katsuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429758/ https://www.ncbi.nlm.nih.gov/pubmed/34504112 http://dx.doi.org/10.1038/s41598-021-96720-x |
Ejemplares similares
-
Smoking cessation in the elderly as a sign of susceptibility to symptomatic COVID-19 reinfection in the United States
por: Ando, Wataru, et al.
Publicado: (2022) -
Risk analysis of COVID-19 hospitalization and critical care by race and region in the United States: a cohort study
por: Jimbo, Mitsuki, et al.
Publicado: (2023) -
Effects of resistant dextrin for weight loss in overweight adults: a systematic review with a meta-analysis of randomized controlled trials
por: Mukai, Junichi, et al.
Publicado: (2017) -
Effects of pharmacist intervention on polypharmacy in patients with type 2 diabetes in Japan
por: Horii, Takeshi, et al.
Publicado: (2020) -
On‐label use of sodium–glucose cotransporter 2 inhibitors might increase the risk of diabetic ketoacidosis in patients with type 1 diabetes
por: Horii, Takeshi, et al.
Publicado: (2021)